ENZON PHARMACEUTICALS, INC. Quarterly Common Stock, Shares, Issued from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Enzon Pharmaceuticals, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q2 2024.
  • Enzon Pharmaceuticals, Inc. Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 74.2M shares, unchanged year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 74.2M 0 0% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 74.2M 0 0% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 74.2M 0 0% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 74.2M 0 0% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 74.2M 0 0% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 74.2M 0 0% Mar 31, 2023 10-Q 2023-05-05
Q4 2022 74.2M 0 0% Dec 31, 2022 10-K 2024-03-20
Q3 2022 74.2M 0 0% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 74.2M 0 0% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 74.2M 0 0% Mar 31, 2022 10-Q 2022-04-26
Q4 2021 74.2M 0 0% Dec 31, 2021 10-K 2023-02-16
Q3 2021 74.2M +30M +67.9% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 74.2M +30M +67.9% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 74.2M +30M +67.9% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 74.2M +30M +67.9% Dec 31, 2020 10-K 2022-02-25
Q3 2020 44.2M 0 0% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 44.2M 0 0% Jun 30, 2020 10-Q 2020-07-29
Q1 2020 44.2M 0 0% Mar 31, 2020 10-Q 2020-04-30
Q4 2019 44.2M 0 0% Dec 31, 2019 10-K 2021-02-23
Q3 2019 44.2M 0 0% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 44.2M 0 0% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 44.2M 0 0% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 44.2M 0 0% Dec 31, 2018 10-K 2020-02-19
Q3 2018 44.2M 0 0% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 44.2M 0 0% Jun 30, 2018 10-Q 2018-08-10
Q1 2018 44.2M 0 0% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 44.2M 0 0% Dec 31, 2017 10-K 2019-02-21
Q3 2017 44.2M 0 0% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 44.2M +348K +0.79% Jun 30, 2017 10-Q 2017-08-10
Q1 2017 44.2M 0 0% Mar 31, 2017 10-Q 2017-05-11
Q4 2016 44.2M 0 0% Dec 31, 2016 10-K 2018-03-21
Q3 2016 44.2M +32.2K +0.07% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 43.9M -316K -0.72% Jun 30, 2016 10-Q 2016-08-10
Q1 2016 44.2M +32.2K +0.07% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 44.2M +40.1K +0.09% Dec 31, 2015 10-K 2017-03-24
Q3 2015 44.2M +40.1K +0.09% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 44.2M +57K +0.13% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 44.2M +88.6K +0.2% Mar 31, 2015 10-Q 2015-05-13
Q4 2014 44.2M +88.6K +0.2% Dec 31, 2014 10-K 2016-03-21
Q3 2014 44.1M +74K +0.17% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 44.1M +394K +0.9% Jun 30, 2014 10-Q 2014-08-08
Q1 2014 44.1M +378K +0.87% Mar 31, 2014 10-Q 2014-05-09
Q4 2013 44.1M +412K +0.94% Dec 31, 2013 10-K 2015-03-05
Q3 2013 44.1M -1.14M -2.52% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 43.7M -3.81M -8.02% Jun 30, 2013 10-Q 2013-08-06
Q1 2013 43.7M -4.58M -9.48% Mar 31, 2013 10-Q 2013-05-10
Q4 2012 43.7M -4.62M -9.56% Dec 31, 2012 10-K 2014-03-14
Q3 2012 45.2M -3.07M -6.35% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 47.5M -3.09M -6.1% Jun 30, 2012 10-Q/A 2012-08-21
Q1 2012 48.3M Mar 31, 2012 10-Q 2012-05-02
Q4 2011 48.3M -10.5M -17.9% Dec 31, 2011 10-K 2013-03-18
Q3 2011 48.3M Sep 30, 2011 10-Q 2011-11-04
Q2 2011 50.6M Jun 30, 2011 10-Q 2011-08-05
Q4 2010 58.8M Dec 31, 2010 10-K 2012-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.